MEDIVATION, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-12-03: Reporting owner Seely Lynn; Form 4; Security Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2007-10-18: Reporting owner Seely Lynn; Form 4; Security Employee Stock Option (right to buy); Transaction Holding.
- 2007-10-18: Reporting owner CHAKRAVARTY SARVAJIT; Form 4; Security Employee Stock Option (right to buy); Transaction Holding.
- 2007-10-18: Reporting owner Hung David; Form 4; Security Employee Stock Option (right to buy); Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-12-03 | Seely Lynn Officer (Chief Medical Officer) | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 324,000 owned after | $3.60 exercise price | 2007-12-05 | |
| 2007-10-18 holding as of filing | Seely Lynn Officer (Chief Medical Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | Holding | 333,000 owned after | $3.60 exercise price | 2007-10-18 | |
| 2007-10-18 holding as of filing | CHAKRAVARTY SARVAJIT Officer (VP of Medicinal Chemistry) | 4 | Employee Stock Option (right to buy) Derivative · Direct | Holding | 75,000 owned after | $18.75 exercise price | 2007-10-18 | |
| 2007-10-18 holding as of filing | Hung David Director, Officer (President and CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | Holding | 150,000 owned after | $11.76 exercise price | 2007-10-18 | |
| 2007-10-18 holding as of filing | Machado Clarence Patrick Officer (Sr. Vice President and CFO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | Holding | 150,000 owned after | $11.76 exercise price | 2007-10-18 | |
| 2007-10-01 | Seely Lynn Officer (Chief Medical Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $21.17 exercise price | 2007-10-18 | |
| 2007-10-01 | CHAKRAVARTY SARVAJIT Officer (VP of Medicinal Chemistry) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,650 6,650 owned after | $21.17 exercise price | 2007-10-18 | |
| 2007-10-01 | Hung David Director, Officer (President and CEO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +220,000 220,000 owned after | $21.17 exercise price | 2007-10-18 | |
| 2007-10-01 | Machado Clarence Patrick Officer (Sr. Vice President and CFO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +150,000 150,000 owned after | $21.17 exercise price | 2007-10-18 | |
| 2007-09-19 | Seely Lynn Officer (Chief Medical Officer) | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 333,000 owned after | $3.60 exercise price | 2007-09-21 | |
| 2007-07-20 holding as of filing | Adams Daniel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | Holding | 91,710 owned after | $3.75 exercise price | 2007-07-20 | |
| 2007-07-20 holding as of filing | Bailey Gregory Director | 4 | Common Stock Option Derivative · Direct | Holding | 50,950 owned after | $3.00 exercise price | 2007-07-20 | |
| 2007-07-20 holding as of filing | BLICKENSTAFF KIM D Director | 4 | Common Stock Option Derivative · Direct | Holding | 101,900 owned after | $3.75 exercise price | 2007-07-20 | |
| 2007-07-20 holding as of filing | VERNON W ANTHONY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | Holding | 101,900 owned after | $4.45 exercise price | 2007-07-20 | |
| 2007-06-15 | Adams Daniel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $18.75 exercise price | 2007-07-20 | |
| 2007-06-15 | Bailey Gregory Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $18.75 exercise price | 2007-07-20 | |
| 2007-06-15 | BLICKENSTAFF KIM D Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,000 30,000 owned after | $18.75 exercise price | 2007-07-20 | |
| 2007-06-15 | VERNON W ANTHONY Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $18.75 exercise price | 2007-07-20 | |
| 2007-06-15 | CHAKRAVARTY SARVAJIT Officer (VP of Medicinal Chemistry) | 4 | Employee Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +75,000 75,000 owned after | $18.75 exercise price | 2007-07-20 | |
| 2007-06-05 | Seely Lynn Officer (Chief Medical Officer) | 4 | Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 342,000 owned after | $3.60 exercise price | 2007-06-07 | |
| 2007-03-16 | Adams Daniel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,190 91,710 owned after | $3.75 exercise price | 2007-03-20 | |
| 2007-03-16 | Seely Lynn Officer (Chief Medical Officer) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −9,000 351,000 owned after | $3.60 exercise price | 2007-03-20 |